1. Home
  2. Labeler Index
  3. Aphena Pharma Solutions - Tennessee, Llc
  4. 71610-062
  5. Product Images: Carvedilol

Product Images Carvedilol

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Carvedilol NDC 71610-062 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Bottle Label 3.125 mg - 71610 0062 53

Bottle Label 3.125 mg - 71610 0062 53

The text is a mixture of English and non-English characters and appears to be a product name for a medication, specifically 3.125mg Carvedilol tablets packaged in a bottle containing 60 tablets.*

Bottle Label 6.25 mg - 71610 0063 53

Bottle Label 6.25 mg - 71610 0063 53

This is a medication called Carvedilol available in a 6.25mg strength with 60 tablets per container. The NOC (Notice of Compliance) number for this medication is 7161008353.*

Bottle Label 12.5 mg - 71610 0066 60

Bottle Label 12.5 mg - 71610 0066 60

This is a medication called Carvedilol available in tablet form. The dosage may either be 12.5mg or 125mg depending on the prescription, with the latter requiring a prescription (S0). The second line may be a reference number or code. The quantity for the 12.5mg dosage is 90 tablets.*

Bottle Label 25 mg - 71610 0067 60

Bottle Label 25 mg - 71610 0067 60

Carvedilol is a medication commonly used to treat high blood pressure and heart failure. The package appears to contain 90 tablets, each containing 25mg of the active ingredient. The product is labeled with a NOC number of 7161006750.*

Aphena Pharma Solutions - TN - Aphena

Aphena Pharma Solutions - TN - Aphena

Figure 1 - figure 1

Figure 1 - figure 1

Figure 2 - figure 2

Figure 2 - figure 2

This appears to be a tabular representation of several demographic and medical variables, likely from a clinical study or trial. The variables include age, race, diabetes status, heart rate, blood pressure, and use of spironolactone medication. However, it is not possible to discern any further information or context without additional information or further data.*

Figure 3 - figure 3

Figure 3 - figure 3

Figure 4 - figure 4

Figure 4 - figure 4

structural formula - structure

structural formula - structure

Not available.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.